HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katsuyoshi Suzuki Selected Research

Ocular Hypertension (Glaucoma, Suspect)

1/2023Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study.
2/2019Correction to: Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension.
6/2018Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katsuyoshi Suzuki Research Topics

Disease

5Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2023 - 04/2015
5Glaucoma
12/2022 - 01/2015
3Ocular Hypertension (Glaucoma, Suspect)
01/2023 - 06/2018
2Inflammation (Inflammations)
01/2023 - 04/2005
2Cicatrix (Scar)
01/2015 - 06/2014
1Peripheral Nervous System Diseases (PNS Diseases)
01/2023
1Neoplasms (Cancer)
01/2023
1Schizophrenia (Dementia Praecox)
11/2022
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2021
1Keratitis
08/2015
1Proliferative Vitreoretinopathy
04/2014
1Uveitis
01/2012
1Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
01/2012
1Pancreatitis
03/2008
1Infections
03/2008

Drug/Important Bio-Agent (IBA)

3Latanoprost (Xalatan)FDA Link
02/2019 - 04/2015
3tafluprostIBA
02/2019 - 08/2015
2Synthetic Prostaglandins (Prostaglandin Analogues)IBA
01/2023 - 08/2015
2Brimonidine Tartrate (Alphagan)FDA LinkGeneric
12/2022 - 11/2021
2brinzolamide (Azopt)FDA Link
12/2022 - 11/2021
2Timolol (Blocadren)FDA LinkGeneric
02/2019 - 06/2018
2CollagenIBA
01/2015 - 04/2014
1KetamineFDA LinkGeneric
11/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2022
1Glutamic Acid (Glutamate)FDA Link
11/2022
1stiripentolIBA
01/2021
1Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric
08/2015
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2015
1Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2014
1Retinal Pigments (Pigments, Visual)IBA
04/2014
1Methotrexate (Mexate)FDA LinkGeneric
01/2012
1Anti-Bacterial Agents (Antibiotics)IBA
03/2008
1biapenem (L 627)IBA
03/2008
1ImipenemFDA Link
03/2008
1Carbapenems (Carbapenem Antibiotics)IBA
03/2008
1Taurocholic Acid (Sodium Taurocholate)IBA
03/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2005

Therapy/Procedure

2Therapeutics
01/2023 - 01/2020
1Drug Therapy (Chemotherapy)
01/2023
1Electrodes (Electrode)
01/2023
1Filtering Surgery
01/2015